Cargando…

Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer

Immunostimulatory monoclonal antibodies can be given in combinations, hence modulating the activity of 2 or more receptors of the immune system. Some of these combinations have been shown to synergize at the elicitation of therapeutically relevant immune responses in transgenic mice developing spont...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales-Kastresana, Aizea, Labiano, Sara, Gütgemann, Ines, Melero, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091451/
https://www.ncbi.nlm.nih.gov/pubmed/25061546
http://dx.doi.org/10.4161/onci.27812
_version_ 1782480768041222144
author Morales-Kastresana, Aizea
Labiano, Sara
Gütgemann, Ines
Melero, Ignacio
author_facet Morales-Kastresana, Aizea
Labiano, Sara
Gütgemann, Ines
Melero, Ignacio
author_sort Morales-Kastresana, Aizea
collection PubMed
description Immunostimulatory monoclonal antibodies can be given in combinations, hence modulating the activity of 2 or more receptors of the immune system. Some of these combinations have been shown to synergize at the elicitation of therapeutically relevant immune responses in transgenic mice developing spontaneous, oncogene-driven tumors, including multifocal hepatocellular carcinomas expressing ovalbumin as a surrogate tumor-associated antigen.
format Online
Article
Text
id pubmed-4091451
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-40914512015-01-16 Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer Morales-Kastresana, Aizea Labiano, Sara Gütgemann, Ines Melero, Ignacio Oncoimmunology Author's View Immunostimulatory monoclonal antibodies can be given in combinations, hence modulating the activity of 2 or more receptors of the immune system. Some of these combinations have been shown to synergize at the elicitation of therapeutically relevant immune responses in transgenic mice developing spontaneous, oncogene-driven tumors, including multifocal hepatocellular carcinomas expressing ovalbumin as a surrogate tumor-associated antigen. Landes Bioscience 2014-01-16 /pmc/articles/PMC4091451/ /pubmed/25061546 http://dx.doi.org/10.4161/onci.27812 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Morales-Kastresana, Aizea
Labiano, Sara
Gütgemann, Ines
Melero, Ignacio
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
title Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
title_full Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
title_fullStr Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
title_full_unstemmed Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
title_short Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
title_sort combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091451/
https://www.ncbi.nlm.nih.gov/pubmed/25061546
http://dx.doi.org/10.4161/onci.27812
work_keys_str_mv AT moraleskastresanaaizea combinationsofimmunostimulatoryantibodieswithsynergisticeffectsagainstspontaneouscancer
AT labianosara combinationsofimmunostimulatoryantibodieswithsynergisticeffectsagainstspontaneouscancer
AT gutgemannines combinationsofimmunostimulatoryantibodieswithsynergisticeffectsagainstspontaneouscancer
AT meleroignacio combinationsofimmunostimulatoryantibodieswithsynergisticeffectsagainstspontaneouscancer